|
Market Closed -
Nyse
21:00:02 16/01/2026 GMT
|
5-day change
|
1st Jan Change
|
|
1,038.40 USD
|
+0.53%
|
 |
-2.37%
|
-3.38%
|
|
01-15 |
Sector Update: Health Care Stocks Softer in Afternoon Trading
|
MT
| |
01-13 |
Oncolytics Biotech Inc. Appoints Yujun Wu as Vice President, Head of Biostatistics
|
CI
| |
01-13 |
Gan & Lee Pharmaceuticals Appoints Dr. John Wang As Senior Vice President And Chief Strategy Officer, Effective January 12, 2026
|
CI
| |
01-12 |
Analyst recommendations: Exxon Mobil, AbbVie, Eli Lilly, JD Sports…
|  | |
01-12 |
Kyverna Therapeutics, Inc. Appoints Christi Shaw as Executive Chairperson of the Board, Effective January 12, 2026
|
CI
| |
01-11 |
Juvena Therapeutics, Inc. announced that it has received $33.5 million in funding from Bison Ventures, Jefferson Life Sciences, Mubadala Capital, Manta Ray Ventures LLC, Eli Lilly and Company
|
CI
| |
01-08 |
Xilio Therapeutics, Inc. Announces Change of Chair of the Board of Directors
|
CI
| |
01-07 |
Viking Therapeutics, Inc. Announces Appointment of Neil Aubuchon as Chief Commercial Officer
|
CI
| |
01-05 |
Novo Nordisk's US public affairs head leaves company, memo shows
|
RE
| |
12-23 |
Novo Nordisk's weight-loss challenge in five charts
|
RE
| |
12-18 |
Global markets live: Micron, Eli Lilly, Oracle, BP plc, Airbus…
| | |
12-18 |
PRESS DIGEST-Canada - Dec 18
|
RE
| |
12-12 |
PRESS DIGEST- Financial Times - December 12
|
RE
| |
12-08 |
Carolyn Bertozzi returns to Lilly board of directors
|
RE
| |
12-03 |
Alnylam Pharmaceuticals Announces Changes to Board of Directors
|
CI
| |
12-01 |
Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound
|
MT
| |
11-21 |
Eli Lilly & Co elects Carolyn R. Bertozzi to board - SEC filing
|
RE
| |
11-21 |
Eli Lilly and Company Announces Appointment of Carolyn R. Bertozzi, Ph.D as New Board Member and Member of Science and Technology Committee and the Ethics and Compliance Committee, Effective December 8, 2025
|
CI
| |
11-17 |
Nxera Pharma Co., Ltd. Announces Executive Changes
|
CI
| |
11-14 |
Novo Nordisk chair touts OTC future for Wegovy as top investor tightens grip
|
RE
| |
11-13 |
Gate Bioscience, Inc. announced that it has received $64.999995 million in funding from Forbion Capital Partners B.V., Eli Lilly and Company, Versant Venture Management, LLC, Andreessen Horowitz LLC, GV Management Company, LLC, Arch Venture Partners, L.P.
|
CI
| |
11-13 |
'Not been pretty': Novo Nordisk faces rare shareholder rebuke over board shake-up
|
RE
| |
11-06 |
Eli Lilly and Company Announces Management Appointments
|
CI
| |
11-05 |
IQVIA Appoints William G. Kaelin Jr. to its board of directors, Effective November 5, 2025
|
CI
| |
11-05 |
Marker Therapeutics, Inc. Appoints Kathryn Penkus Corzo to Board of Directors, Effective November 1, 2025
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
